{"entity":{"id":"velorum-therapeutics","kind":"company","name":"Velorum Therapeutics","aka":[],"tldr":"Velorum is developing cancer drugs that exploit heme, the iron-carrying molecule tumours depend on in unusual ways.","summary":"Velorum Therapeutics develops medicines built on the biology of heme, the iron-containing molecule central to oxygen transport and cellular metabolism, on the premise that tumour cells handle heme differently from normal cells and that this can be exploited therapeutically. The company is tagged oncology in the YC directory; its public materials give limited detail on targets or candidates, and work is preclinical. No sourced financing rounds are recorded.","asOf":"2026-09-10","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/velorum-therapeutics"},{"label":"Official website","url":"https://www.velorumtx.com"}],"tags":["yc"],"related":[],"cancers":[],"sections":["targeted-therapy","drug-discovery"],"technologies":["kinase-inhibitors"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"San Francisco, CA","country":"US","companyType":"biotech","website":"https://www.velorumtx.com","stage":"startup","ycBatch":"W24","investors":["y-combinator"],"funding":[]},"route":"/companies/velorum-therapeutics/","neighbours":{"section":[{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"},{"id":"targeted-therapy","kind":"section","name":"Targeted Therapy","route":"/fronts/targeted-therapy/"}],"technology":[{"id":"kinase-inhibitors","kind":"technology","name":"Small-molecule kinase inhibitors","route":"/technologies/kinase-inhibitors/"}],"company":[{"id":"y-combinator","kind":"company","name":"Y Combinator","route":"/companies/y-combinator/"}]}}